CONSOLIDATED STATEMENT OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net income (loss)	$ 61,509	$ (179,276)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	15,604	17,911
Amortization and impairment of intangible assets	3,723	4,558
Provision for loan and lease losses	85,658	220,782
Deferred income tax (benefit) expense	(2,815)	(2,577)
Stock-based compensation	2,962	2,088
Gain on sales of investments, net	(291)	0
Other-than-temporary impairments on debt securities	245	117
Other-than-temporary impairements on equity securities	0	42
Equity in losses of unconsolidated entities	7,280	10,798
Impairement of collateral pledged to Lehman	0	66,574
Derivative instruments and financial liabilities measured at fair value, gain	(820)	(762)
Loss (gain) on sale of premises and equipment and other assets	20	(4)
Net gain on sale of loans held for investment	(5,498)	(6,253)
Net amortization of premiums, discounts and deferred loan fees and costs	(1,966)	(3,248)
Originations and purchases of loans held for sale	(223,602)	(400,614)
Sales and repayments of loans held for sale	234,698	461,510
Loans held for sale valuation adjustment	0	6,553
Amortization of broker placement fees	5,140	6,094
Net amortization of premium and discounts on investment securities	3,348	7,473
(Decrease) increase in accrued income tax payable	2,847	1,130
(Increase) decrease in accrued interest receivable	5,496	1,823
Decrease in accrued interest payable	4,620	1,345
Decrease (increase) in other assets	25,536	22,400
Increase (decrease) in other liabilities	13,206	24,076
Net cash provided by operating activities	236,900	262,540
Cash flows from investing activities:
Principal collected on loans	2,533,504	2,081,371
Loans originated and purchased	(2,410,182)	(2,362,492)
Proceeds from sale of loans held for investment	31,558	309,024
Proceeds from sale of repossessed assets	51,399	70,805
Proceeds from sale of available-for-sale securities	4,855	0
Purchases of securities available for sale	(133,596)	(690,377)
Proceeds from principal repayments and maturities of securities available for sale	171,016	280,694
Additions to premises and equipment	(17,863)	(8,919)
Proceeds from sale of premises and equipment and other assets	1,269	4
(Increase) decrease in other equity securities	2,939	6,661
Net cash provided by investing activities	234,899	(313,229)
Cash flows from financing activities:
Net decrease in deposits	(181,890)	83,557
Net FHLB advances paid	25,000	(155,000)
Payments Of Stock Issuance Costs	62	0
Repurchase of outstanding common stock	523	335
Net cash provided (used in) financing activities	(157,475)	(71,778)
Net increase in cash and cash equivalents	314,324	(122,467)
Cash and cash equivalents at beginning of period	655,671	946,851
Cash and cash equivalents at end of period	969,995	824,384
Cash and cash equivalents include:
Cash and due from banks	953,038	623,019
Money market instruments	16,957	201,365
Cash and Cash Equivalents, at Carrying Value, Total	$ 969,995	$ 824,384